Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Affluent Medical

Regulatory Filings • Jul 25, 2023

1082_rns_2023-07-25_613f3a82-b861-4548-b380-515a5e1fc69f.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Half-year liquidity contract statement

Affluent Medical (Euronext Paris: FR0013333077 – AFME) Public limited company with a capital of € 30 896 652 Registered office: 320, avenue Archimède Les Pléiades III - Bâtiment B 13100 Aix-en-Provence - France 837 722 560 R.C.S. on the Aix-en-Provence Trade and Companies Register

Under the liquidity contract entered into between Affluent Medical and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2023:

  • ✓ 124,232 shares
  • ✓ € 39,485.10
  • ✓ Number of executions on buy side on semester: 245
  • ✓ Number of executions on sell side on semester: 129
  • ✓ Traded volume on buy side on semester: 35,717 shares for € 50,544.84
  • ✓ Traded volume on sell side on semester: 21,629 shares for € 32,173.80

As a reminder:

• the following resources appeared on the last half year statement on 31 December 2022 on the liquidity account:

  • ✓ 110,144 shares
  • ✓ € 22,697.72
  • ✓ Number of executions on buy side on semester: 333
  • ✓ Number of executions on sell side on semester: 208
  • ✓ Traded volume on buy side on semester: 32,258 shares for € 82,181.80
  • ✓ Traded volume on sell side on semester: 13,900 shares for € 33,571.60
  • the following resources appeared on the liquidity account when the activity started:
    • ✓ 0 shares
    • ✓ € 400,000.00

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

Aggregate buy/sell transactions for each trading day Period from 02/01/2023 to 30/06/2023

BUY SIDE SELL SIDE
DATE Number of
executions		 Number of
shares		 Traded
volume in EUR		 Number of
executions		 Number of
shares		 Traded
volume in
EUR
02/01/2023 4 400 660.00 - - -
04/01/2023 - - - 1 100 166.00
05/01/2023 - - - 2 5 8.30
06/01/2023 1 1 1.66 1 1 1.66
09/01/2023 - - - 2 158 267.02
10/01/2023 3 300 501.00 - - -
11/01/2023 1 200 334.00 1 137 231.53
12/01/2023 3 400 664.00 - - -
16/01/2023 2 200 332.00 2 200 340.00
17/01/2023 3 600 996.00 - - -
18/01/2023 1 200 328.00 2 200 338.00
19/01/2023 3 201 337.68 1 1 1.70
20/01/2023 1 1 1.68 1 1 1.68
24/01/2023 4 700 1 169.00 - - -
25/01/2023 4 601 997.66 1 1 1.70
30/01/2023 1 200 328.00 1 1 1.67
31/01/2023 1 50 81.50 - - -
01/02/2023 2 55 89.65 - - -
02/02/2023 - - - 1 68 113.56
03/02/2023 - - - 2 170 283.90
06/02/2023 - - - 2 61 101.87
09/02/2023 3 296 482.48 1 1 1.63
10/02/2023 6 1 000 1 470.00 - - -
13/02/2023 - - - 5 600 918.00
14/02/2023 4 770 1 185.80 1 200 320.00
15/02/2023 3 400 592.00 - - -
16/02/2023 5 524 765.04 - - -
17/02/2023 6 876 1 261.44 - - -

BUY SIDE SELL SIDE
DATE Number of
executions		 Number of
shares		 Traded
volume in
EUR		 Number of
executions		 Number of
shares		 Traded
volume in
EUR
20/02/2023 1 200 284.00 - - -
21/02/2023 1 1 1.40 5 501 726.45
22/02/2023 3 400 572.00 2 400 592.00
23/02/2023 7 1 200 1 848.00 15 3 006 4 779.54
24/02/2023 12 1 802 2 703.00 1 194 310.40
27/02/2023 3 1 300 1 950.00 2 71 113.60
28/02/2023 2 200 296.00 - - -
01/03/2023 4 600 870.00 - - -
02/03/2023 6 900 1 260.00 6 1 792 2 795.52
03/03/2023 4 873 1 292.04 - - -
06/03/2023 8 1 427 1 997.80 - - -
07/03/2023 4 901 1 234.37 2 501 711.42
08/03/2023 4 900 1 215.00 - - -
09/03/2023 2 1 000 1 400.00 12 5 508 8 262.00
10/03/2023 1 500 705.00 2 2 000 2 900.00
13/03/2023 1 500 720.00 1 1 000 1 480.00
14/03/2023 3 501 721.44 1 1 1.45
15/03/2023 2 1 001 1 401.40 1 1 1.45
16/03/2023 10 2 775 3 718.50 - - -
17/03/2023 1 225 292.50 3 1 001 1 361.36
20/03/2023 1 200 260.00 - - -
22/03/2023 1 1 1.31 1 1 1.31
23/03/2023 2 201 261.30 1 1 1.36
24/03/2023 1 1 1.34 2 201 271.35
27/03/2023 2 200 260.00 - - -
28/03/2023 1 1 1.35 1 1 1.35
29/03/2023 2 201 261.30 2 101 136.35
30/03/2023 1 1 1.30 1 1 1.30
31/03/2023 1 1 1.31 1 1 1.31
03/04/2023 1 200 250.00 - - -

BUY SIDE SELL SIDE
DATE Number of
executions		 Number of
shares		 Traded
volume in
EUR		 Number of
executions		 Number of
shares		 Traded
volume in
EUR
05/04/2023 1 1 1.24 1 1 1.24
06/04/2023 - - - 2 400 532.00
11/04/2023 1 200 260.00 - - -
13/04/2023 2 201 251.25 2 200 260.00
14/04/2023 5 1 500 1 815.00 1 1 1.30
17/04/2023 2 200 234.00 1 200 250.00
18/04/2023 1 200 250.00 - - -
20/04/2023 1 1 1.25 1 1 1.25
21/04/2023 1 1 1.20 - - -
24/04/2023 2 200 242.00 - - -
25/04/2023 - - - 1 200 250.00
04/05/2023 2 65 81.25 - - -
05/05/2023 1 135 168.75 - - -
09/05/2023 1 1 1.29 3 401 517.29
10/05/2023 1 199 256.71 - - -
11/05/2023 4 400 516.00 2 1 200 1 668.00
12/05/2023 4 800 1 104.00 2 517 739.31
15/05/2023 5 200 280.00 - - -
16/05/2023 4 600 816.00 - - -
17/05/2023 1 9 11.97 - - -
18/05/2023 4 601 793.32 1 1 1.34
19/05/2023 5 600 804.00 - - -
22/05/2023 4 800 1 032.00 1 1 1.35
23/05/2023 1 1 1.35 2 50 67.50
25/05/2023 1 43 54.18 - - -
26/05/2023 1 1 1.30 1 1 1.30
29/05/2023 2 11 13.86 1 1 1.30
30/05/2023 1 1 1.30 1 1 1.30
31/05/2023 3 348 445.44 1 1 1.34
01/06/2023 3 201 261.30 1 1 1.30

BUY SIDE SELL SIDE
DATE Number of
executions		 Number of
shares		 Traded
volume in
EUR		 Number of
executions		 Number of
shares		 Traded
volume in
EUR
02/06/2023 1 1 1.30 1 1 1.30
05/06/2023 3 200 260.00 - - -
08/06/2023 1 200 260.00 - - -
09/06/2023 1 1 1.30 1 1 1.30
12/06/2023 2 100 128.00 - - -
13/06/2023 1 100 126.00 - - -
15/06/2023 1 1 1.29 1 1 1.29
19/06/2023 1 1 1.29 1 1 1.29
20/06/2023 4 326 407.50 1 1 1.27
21/06/2023 2 76 94.24 1 1 1.25
22/06/2023 1 1 1.25 1 1 1.25
23/06/2023 2 31 37.82 1 1 1.24
26/06/2023 1 170 207.40 2 200 250.00
27/06/2023 1 1 1.24 4 54 67.50
28/06/2023 4 400 484.00 1 1 1.25
30/06/2023 2 400 472.00 - - -
TOTAL 245 35 717 50 544.84 129 21 629 32 173.80

About Affluent Medical

Affluent Medical is a French MedTech company, founded by Truffle Capital, with the ambition to become a global leader in the treatment of structural heart diseases, which are the world's leading cause of mortality, and urinary incontinence which currently affects one in four adults.

Affluent Medical develops next-generation, mini-invasive, innovative, adjustable, and biomimetic implants to restore critical physiological functions. The product candidates developed by the Company are currently in preclinical and clinical studies.

Subject to raising the necessary funds to finance its strategy and to positive results from ongoing clinical studies, the Company's ambition is to progressively commercialize its products starting in 2025.

For more information: www.affluentmedical.com

AFFLUENT MEDICAL Sébastien LADET

Chief Executive Officer [email protected]

PRIMATICE, public relations France Thomas ROBOREL de CLIMENS +33 (0)6 78 12 97 95

[email protected]

ACTIFIN, financial communications/ financial press relations Ghislaine GASPARETTO/ Jennifer JULLIA +33 (0)6 21 10 49 24/ +33 (0)1 56 88 11 19 [email protected]/ jjullia@actifin.fr

MC Services AG

Caroline BERGMANN / Kirsten RÜHL +49 (0)211 529252 20 / +49 (0)211 529252 16 [email protected]

More from Affluent Medical

Declaration of Voting Results & Voting Rights Announcements 2025
Nov 5
Declaration of Voting Results & Voting Rights Announcements 2025
Nov 5
Regulatory Filings 2025
Oct 30
Declaration of Voting Results & Voting Rights Announcements 2025
Oct 3
Earnings Release 2025
Sep 30
Regulatory Filings 2025
Sep 29
Regulatory Filings 2025
Sep 29
Regulatory Filings 2025
Sep 29
Capital/Financing Update 2025
Jul 8
Regulatory Filings 2025
Jul 8
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.